In addition to these lesions associated with theBCR-ABL1-like phenotype, aberrations resulting in the activation of the Ras/Raf/MAPK pathway (hereafter, Ras pathway) occur frequently across various BCP-ALL subtypes58–62. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.